MedTrace Logo

Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis

NCT02692495 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2018-02-22

Study results available
· View outcomes & findings →

Summary

This study is designed as a retrospective cohort study to evaluate the potential of diagnostic procedures in defining populations of patients self-reporting unexpected and uncontrollable episodes of body odor and/or halitosis. The cohort - generally healthy individuals who had underwent multiple diagnostic tests recommended by their physicians and had not been diagnosed with any known medical condition - expressed their interest in trying gastrointestinal and nutritional diagnostic tests offered by Biolab Medical Unit. Our retrospective analysis will determine if these tests were useful as potential screening tools for metabolic body odor and halitosis.

Conditions

  • Nutritional and Metabolic Diseases

Sponsors & Collaborators

  • Mebo Research, Inc.

    lead OTHER

Principal Investigators

  • Irene Gabashvili, PhD · MeBO Research

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2013-12-31
Completion
2016-02-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02692495 on ClinicalTrials.gov